PJP Holdings Information

PJP is an equity ETF with a total of 35 individual holdings. The top holdings are AbbVie stock at 5.26%, Abbott Laboratories at 5.08%, Johnson & Johnson at 5.05%, Eli Lilly and Company at 4.87%, and Gilead Sciences at 4.85%.

Total Holdings

Top 10 Percentage

46.79%

Asset Class

Equity

ETF Category

Health

Assets

258.80M

PE Ratio

16.86

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	5.26%	62,525
2	ABT	Abbott Laboratories	5.08%	99,003
3	JNJ	Johnson & Johnson	5.05%	73,816
4	LLY	Eli Lilly and Company	4.87%	17,700
5	GILD	Gilead Sciences, Inc.	4.85%	113,532
6	PFE	Pfizer Inc.	4.75%	522,784
7	AMGN	Amgen Inc.	4.70%	44,988
8	MRK	Merck & Co., Inc.	4.58%	153,286
9	TVTX	Travere Therapeutics, Inc.	3.86%	407,458
10	UTHR	United Therapeutics Corporation	3.77%	22,980
11	CORT	Corcept Therapeutics Incorporated	3.26%	102,143
12	SUPN	Supernus Pharmaceuticals, Inc.	2.91%	160,336
13	LGND	Ligand Pharmaceuticals Incorporated	2.86%	44,480
14	AVDL	Avadel Pharmaceuticals plc	2.83%	478,523
15	AMRX	Amneal Pharmaceuticals, Inc.	2.80%	757,576
16	JAZZ	Jazz Pharmaceuticals plc	2.80%	56,848
17	ANIP	ANI Pharmaceuticals, Inc.	2.78%	77,332
18	OCUL	Ocular Therapeutix, Inc.	2.72%	577,494
19	BIIB	Biogen Inc.	2.72%	51,975
20	PCRX	Pacira BioSciences, Inc.	2.70%	273,415
21	REGN	Regeneron Pharmaceuticals, Inc.	2.59%	12,092
22	PBH	Prestige Consumer Healthcare Inc.	2.59%	107,003
23	TARS	Tarsus Pharmaceuticals, Inc.	2.58%	120,749
24	INVA	Innoviva, Inc.	2.55%	356,551
25	BMY	Bristol-Myers Squibb Company	2.52%	150,520

Showing 25 of 35 holdings

Subscribe to see the full list

Upgrade Now

As of Sep 25, 2025